Breast cancer risk with hormone replacement after risk-reducing salpingo-oophorectomy in BRCA mutation carriers: Does it abrogate the benefit?
Barlin, J.N., Arnold, A., Mobley, S., Otegbeye, E., Stadler, Z.K., Robson, M.E., Offit, K., Barakat, R.R., Kauff, N.D.Volume:
133
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2014.03.213
Date:
June, 2014
File:
PDF, 226 KB
english, 2014